Buy Rating for Arcellx Inc. Based on Promising Efficacy and Safety of BCMA CAR-T Therapy in IMMagine-1 Study

TipRanksDec 12 15:06 · Ratings

Morgan Stanley Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $111

Futu NewsDec 11 21:33 · Ratings

Truist Financial Initiates Arcellx(ACLX.US) With Buy Rating

Futu NewsDec 11 21:33 · Ratings

A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $111 to $122

Futu NewsDec 11 21:00 · Ratings

Arcellx Inc (ACLX) Gets a Buy From Truist Financial

TipRanksDec 11 20:56 · Ratings

Promising Outlook for Arcellx Inc: Anito-cel Therapy Positioned as a Safer Alternative With Strong Market Potential

TipRanksDec 11 18:45